🔗 Permalink

Inventor profile of:

Rita Steeves

City:

Stoneham, Massachusetts

Country:

United States

Published Applications:

17

Last publication date:

2024-11-07

Top Assignees for applications by Rita Steeves

The entities that hold a legal rights for patent applications filed by inventor Steeves Rita:

ImmunoGen, INC. 7 Waltham, MA United States
Acceleron Pharma, Inc. 6 Cambridge, MA United States
Immunogen, Inc. 4 Cambridge, MA United States
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 3 Boston, MA United States
The Bringham and Women's Hospital, Inc. 1 Boston, MA United States
ACCLERON PHARMA INC. 1 Cambridge, MA United States

Recent patent applications by Steeves Rita

Rita Steeves from Stoneham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-07

US20240366720A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#2 | 2021-07-29

US20210230252A1

Chemistry; metallurgy

TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOF

#3 | 2020-10-15

US20200323955A1

Human necessities

Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor

#4 | 2020-05-21

US20200157182A1

Chemistry; metallurgy

Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides

#5 | 2019-09-19

US20190284257A1

Chemistry; metallurgy

Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide

#6 | 2018-06-28

US20180179261A1

Chemistry; metallurgy

Transforming growth factor-beta receptor type II fusion polypeptides

#7 | 2016-12-29

US20160376341A1

Chemistry; metallurgy

Transforming growth factor beta receptor II fusion polypeptides

#8 | 2016-10-06

US20160287664A1

Human necessities

Methods for treating pulmonary hypertension with a TGF-beta type II receptor-FC fusion protein

#9 | 2015-02-26

US20150056199A1

Chemistry; metallurgy

TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOF

#10 | 2011-12-29

US20110319612A1

Chemistry; metallurgy

Elimination of heterogeneous or mixed cell population in tumors

#11 | 2009-03-19

US20090076263A1

Chemistry; metallurgy

Elimination of heterogeneous or mixed cell population in tumors

#12 | 2008-07-17

US20080171865A1

Chemistry; metallurgy

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates

#13 | 2008-07-17

US20080171856A1

Chemistry; metallurgy

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates

#14 | 2008-06-19

US20080145374A1

Chemistry; metallurgy

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates

#15 | 2008-05-15

US20080114153A1

Chemistry; metallurgy

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates

#16 | 2006-10-19

US20060233814A1

Chemistry; metallurgy

Elimination of heterogeneous or mixed cell population in tumors

#17 | 2005-08-04

US20050169933A1

Chemistry; metallurgy

Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates

InventorID:

1078654 ⎘